(lp0
S"Why Kythera Biopharmaceuticals, Inc Rocketed Higher Motley Fool - Mar 5, 2015 After reporting positive results in clinical trials, Kythera submitted its filing for FDA approval for ATX-101 last May. In ATX-101's trials, the drug, which is a formulation of a molecule that breaks down fat, visibly reduced the amount of fat under ..."
p1
aS'Allergan to Buy Kythera Biopharmaceuticals for $2.1 Billion Bloomberg - Jun 17, 2015 Allergan Plc, the maker of wrinkle treatment Botox, agreed to buy Kythera Biopharmaceuticals Inc. for about $2.1 billion to add treatments for double chins and male pattern baldness.Why Kythera Biopharmaceuticals, Inc. Stock Soared Today - Motley FoolAllergan to Acquire KYTHERA Biopharmaceuticals - PR Newswire '
p2
aS'KYTHERA Biopharmaceuticals Appoints Hollings C. Renton to Board of Directors GlobeNewswire  - Jan 5, 2015 WESTLAKE VILLAGE, Calif., Jan. 5, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced that it has named Hollings C. Renton to its Board of Directors.'
p3
aS'KYTHERA Biopharmaceuticals Announces US Availability of KYBELLA -- First ... GlobeNewswire  - Jun 19, 2015 WESTLAKE VILLAGE, Calif., June 19, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced the U.S.KYTHERA Soars on $2.1 Billion Buyout Offer from Allergan - Analyst Blog - Nasdaq'
p4
aS"Photo Release -- KYTHERA Biopharmaceuticals Announces FDA Approval of KYBELLA ... GlobeNewswire  - Apr 29, 2015 WESTLAKE VILLAGE, Calif., April 29, 2015  -- KYTHERA Biopharmaceuticals, Inc.  announced today that the U.S.FDA approves Westlake Village company's drug to reduce double-chin fat - Los Angeles TimesFDA approves treatment for fat below the chin - FDA.gov"
p5
aS"Sell Kythera  Stock, Another Biotech Ripoff Investorplace.com - Mar 9, 2015 Kythera Biopharmaceuticals Inc  stock was halted Monday as an independent advisory committee reviewed its double-chin treatment, ATX-101.FDA Panel Backs Kythera Double-Chin Treatment - Wall Street JournalThe FDA voted to approve a drug that reduces 'double chin' - Business Insider"
p6
aS'KYTHERA Biopharmaceuticals Submits Investigational New Drug Application for ... GlobeNewswire  - Sep 22, 2015 WESTLAKE VILLAGE, Calif., Sept. 22, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced it has submitted an Investigational New Drug Application  to the U.S.'
p7
aS'KYTHERA Acquires Worldwide Rights to Clinical Compound and Key Intellectual ... GlobeNewswire  - Feb 10, 2015 WESTLAKE VILLAGE, Calif., Feb. 10, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced that it has entered into separate license agreements with Actelion Pharmaceuticals Ltd.Kythera Biophrarma  Enters Hair Loss IP Agreement with Actelion Pharma ... - StreetInsider.com'
p8
aS'KYTHERA Biopharmaceuticals Submits New Drug Application for ATX-101 as First ... GlobeNewswire  - May 12, 2014 CALABASAS, Calif., May 12, 2014  -- KYTHERA Biopharmaceuticals, Inc.  today announced it has submitted a New Drug Application  to the U.S.'
p9
aS'Kythera Biopharmaceuticals, Inc.  Reviewed By Analysts The De Soto Edge - Mar 8, 2017 Stock market analysts watching Kythera Biopharmaceuticals, Inc.  have recently changed their ratings on the stock.'
p10
a.